Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study.

Authors:
Address: Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 1033, University of Lyon, Hôpital Edouard Herriot, Pavillon F, Place d'Arsonval, Lyon, F-69437 France.
Journal:


Publication:

abstract

CONTEXT:

calcification inhibitor deficiencies, mineral imbalance, and phenotypic transformation of vascular cells to osteogenic cells initiate and sustain vascular calcification. Fibroblast growth factor-23 (FGF23) is a key molecule regulating mineral homeostasis.

OBJECTIVE:

Our objective was to assess the association of Serum FGF23 levels with mineral metabolism parameters and abdominal aortic calcification (AAC) in men.

DESIGN:

This was a cross-sectional analysis in the STRAMBO cohort.

SETTING:

Men holding a private health insurance cover with Mutuelle de Travailleurs de la Région Lyonnaise were included in the study.

PARTICIPANTS:

Participants included male volunteers aged 20-87 (n = 1130). Interventions: Nonfasting blood collection was done. AAC was semiquantitatively assessed from vertebral fracture assessment scans obtained using dual-energy x-ray absorptiometry.

MAIN OUTCOME MEASURES:

We evaluated the association between FGF23 concentration and AAC severity in men.

RESULTS:

In 350 men aged 60 yr or younger, FGF23 levels decreased with age (r = -0.21; P < 0.001) but were not associated with any other parameter. In 780 men aged over 60 yr, serum FGF23 correlated with age (r = 0.37; P < 0.001) and, after adjustment for confounders, with glomerular filtration rate (r = -0.31; P < 0.001) and PTH levels (r = 0.25; P < 0.001). After adjustment for confounders, self-reported ischemic heart disease, diabetes mellitus as well as higher concentrations of C-reactive protein and osteoprotegerin were all associated with higher FGF23 levels. After adjustment for confounders, subjects in the highest FGF23 quartile had higher prevalence of severe AAC compared with the three lower quartiles combined (odds ratio = 1.88; 95% confidence interval = 1.22-2.85; P < 0.005).

CONCLUSIONS:

In healthy older men, circulating FGF23 is associated with parameters of mineral metabolism, including bone metabolism-regulating cytokines, and with severe AAC independent of traditional risk factors.



Related Articles
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
Abdominal aortic calcification, BMD, and bone microstructure: a population-based study.
J Bone Miner Res. 2008
Abdominal aortic calcification, BMD, and bone microstructure: a population-based study.
Chow JT, Khosla S, Melton LJ 3rd, Atkinson EJ, Camp JJ, Kearns AE. J Bone Miner Res. 2008 Oct; 23(10):1601-12.
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
Osteoporos Int. 2011
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA, on behalf of the European Uremic Toxin (EUTox) Work Group. Osteoporos Int. 2011 Nov 23; . Epub 2011 Nov 23.
Association of osteocalcin and abdominal aortic calcification in older women: the study of osteoporotic fractures.
Calcif Tissue Int. 2010
Association of osteocalcin and abdominal aortic calcification in older women: the study of osteoporotic fractures.
Parker BD, Bauer DC, Ensrud KE, Ix JH. Calcif Tissue Int. 2010 Mar; 86(3):185-91. Epub 2010 Jan 23.
Review Effectiveness and safety of vitamin D in relation to bone health.
Evid Rep Technol Assess (Full ...
Review Effectiveness and safety of vitamin D in relation to bone health.
Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, et al. Evid Rep Technol Assess (Full Rep). 2007 Aug; (158):1-235.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.